The SUSTAIN 6 trial demonstrated that semaglutide reduced major adverse cardiovascular events (a composite of cardiovascular death, nonfatal heart attack, and nonfatal stroke) by 26% in patients with type 2 diabetes and established cardiovascular disease
Also, as food sits in your stomach and colon, it can begin to ferment, producing gas, bloating, and heartburn along with constipation and diarrhea - often like a very unpleasant rollercoaster in cycles
In the SURPASS clinical trial program for type 2 diabetes, patients achieved HbA1c reductions of 1.9% to 2.6% depending on dose, with weight loss averaging 15-22 pounds across studies
We provide 24/7 access to specialists who can guide you through every aspect of your program, including storage concerns, dosage changes, and managing side effects
Transitioning from compounded ODT to injectable The transition from a compounded oral formulation to FDA-approved injectable tirzepatide requires coordination with a healthcare provider
These sublingual tablets dissolve under the tongue, allowing the medication to be absorbed directly into the bloodstream without passing through the digestive system first
